Portal de Periódicos da CAPES

MALIGNANCY AND HAEMOSTASIS

1980; Wiley; Volume: 44; Issue: 2 Linguagem: Inglês

10.1111/j.1365-2141.1980.tb01199.x

1365-2141

Maria Benedetta Donati, Andreina Poggi,

Chronic Myeloid Leukemia Treatments

British Journal of HaematologyVolume 44, Issue 2 p. 173-182 MALIGNANCY AND HAEMOSTASIS Maria Benedetta Donati, Corresponding Author Maria Benedetta Donati Laboratory for Haemostasis and Thrombosis Research, Istituto di Ricerche Farmacologiche ‘Mario Negri’, Milan, ItalyDr Maria Benedetta Donati, Istituto di Ricerche Farmacologiche ‘Mario Negri’, Via Eritrea 62, 20157 Milan, Italy.Search for more papers by this authorAndreina Poggi, Andreina Poggi Laboratory for Haemostasis and Thrombosis Research, Istituto di Ricerche Farmacologiche ‘Mario Negri’, Milan, ItalySearch for more papers by this author Maria Benedetta Donati, Corresponding Author Maria Benedetta Donati Laboratory for Haemostasis and Thrombosis Research, Istituto di Ricerche Farmacologiche ‘Mario Negri’, Milan, ItalyDr Maria Benedetta Donati, Istituto di Ricerche Farmacologiche ‘Mario Negri’, Via Eritrea 62, 20157 Milan, Italy.Search for more papers by this authorAndreina Poggi, Andreina Poggi Laboratory for Haemostasis and Thrombosis Research, Istituto di Ricerche Farmacologiche ‘Mario Negri’, Milan, ItalySearch for more papers by this author First published: February 1980 https://doi.org/10.1111/j.1365-2141.1980.tb01199.xCitations: 91AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat REFERENCES Ambrus, J.L., Ambrus, C.M. & Gastpar, H. (1978) Studies on platelet aggregation and platelet interaction with tumor cells. Platelets: A Multidisciplinary Approach (ed. by G. Gaetano and S. Garattini), pp. 467–480. Raven Press, New York . Ambrus, J.L., Ambrus, C.M., Pickern, J., Soldes, S. & Bross, I. (1975) Hematologic changes and thromboembolic complications in neoplastic disease and their relationship to metastasis. Journal of Medicine, 6, 433–458. Anaclerio, A., Ruggeri, A., Poggi, A., Spreafico, F. & Donati, M.B. (1979) In vivo and in vitro immunosuppressive effect of two batioxobin preparations in mice. Thrombosis Research, (in press). ÅStedt, B. & Holmberg, L. (1976) Immunological identity of urokinase and ovarian carcinoma plasminogen activator released in tissue culture. Nature, 261, 595–597. Beers, W.H., Strickland, S. & Reich, E. (1975) Ovarian plasminogen activator: relationship to ovulation and hormonal regulation. Cell, 6, 387–394. Chang, J.C. & Hall, T.C. (1973) In vitro effect of sodium warfarin on DNA and RNA synthesis of mouse L 1210 leukemic cells and Walker tumor cells. Oncology, 28, 232–237. Chen, L.B. & Buchanan, J.M. (1975) Mitogenic activity of blood components. I. Thrombin and prothrombin. Proceedings of the National Academy of Sciences of the United States of America, 72, 131–135. Cliffton, E.E. & Grossi, C.E. (1956) Effect of human plasmin on toxic effects and growth of blood-borne metastasis of Brown-Pearce carcinoma and V2 carcinoma of rabbit. Cancer, 9, 1147–1152. Curatolo, L., Colucci, M., Cambini, A.L., Poggi, A., Morasca, L., Donati, M.B. & Semeraro, N. (1979) Evidence that cells from experimental tumours have coagulation factor X activating activity. British Journal of Cancer, 40, 228–233. DeWys, W.D., Kwaan, H.C. & Bathina, S. (1976) Effect of defibrination on tumor growth and response to chemotherapy. Cancer Research, 36, 3584–3587. Dolfini, E., Azzarone, B., Pedullà, D., Ottaviano, E., De Gaetano, G., Donati, M.B. & Morasca, L. (1976) Characterization of human fibroblasts from cancer patients: loss of fibrin clot retractile activity after ‘in vitro’ spontaneous transformation. European Journal of Cancer, 12, 823–825. Donati, M.B., Balconi, G., Remuzzi, G., Borgia, R., Morasca, L. & De Gaetano, G. (1977a) Skin fibroblasts from a patient with Glanzmann's thrombasthenia do not induce fibrin clot retraction. Thrombosis Research, 10, 173–174. Donati, M.B., Curatolo, L., Borgia, R., Balconi, G., Morasca, L. (1978a) Fibrin clot retraction by cultured human fibroblasts. Platelets: A Multidisciplinary Approach (ed. by G. Gaetano and S. Garattini), pp. 149–158. Raven Press, New York . Donati, M.B., Dolfini, E., Morasca, L. & De Gaetano, G. (1976) Fibrin clot retraction by a rat rhabdomyosarcoma cell line. Thrombosis Research, 8, 707–711. Donati, M.B., Mussoni, L., Poggi, A., De Gaetano, G. & Garattini, S. (1978b) Growth and metastasis of the Lewis lung carcinoma in mice defibrinated with batroxobin. European Journal of Cancer, 14, 343–347. Donati, M.B., Poggi, A., Mussoni, L., De Gaetano, G. & Garattini, S. (1977b) Hemostasis and experimental cancer dissemination. Cancer Invasion and Metastasis: Biologic Mechanisms and Therapy (ed. by S. B. Day, W. P. L. Myers, P. Stansly, S. Garattini and M. G. Lewis), pp. 151–160. Raven Press, New York . Donelli, M.G., Colombo, T., Ghersa, P., Poggi, A., Barbieri, B., Ferrari, R. & Broggini, M. (1979) Anthracyclines and drug interaction. European Journal of Cancer, (in press). Drapkin, R.L., Gee, T.S., Dowling, M.D., Arilin, Z., McKenzie, S., Kempin, S. & Clarkson, B. (1978) Prophylactic heparin therapy in aute promyelocytic leukemia. Cancer, 41, 2484–2490. Easty, G.C. & Easty, D.M. (1976) Prostaglandins and cancer. Cancer Treatment Reviews, 3, 217–225. Edlis, H.E., Goudsmith, A., Brindley, C. & Niemetz, J. (1976) Trial of heparin and cyclophosphamide (NSC-26271) in the treatment of lung carcinoma. Cancer Treatment Reports, 60, 575–578. Edwards, R.L. & Rickles, F.R. (1978) Delayed hypersensitivity in man: effects of systemic anticoagulation. Science, 200, 541–543. Elias, E.G. & Brugarolas, A. (1972) The role of heparin in the chemotherapy of solid tumors. Preliminary clinical trial in carcinoma of the lung. Cancer Chemotherapy Reports, 56, 783–785. Elias. E.G., Shukla, S.K. & Mink, I.B. (1975) Heparin and chemotherapy in the management of inoperable lung carcinoma. Cancer, 36, 129–136. Fidler, I.J. (1975) Biological behavior of malignant melanoma cells correlated to their survival ‘in vivo’. Cancer Research, 35, 218–244. Gabbiani, G., Borgia, R., Chaponnier, C., Zumbe, A. & Weil, R. (1977) Cytoskelctal proteins in normal infected and virus-transformed cells. Early Proteins of Oncogenic DNA Viruses, Vol. 69, pp. 303–310. INSERM, Paris . Gabbiani, G., Csank-Brassert, J., Schneeberger, J.C., Kapanci, Y., Trenchev, P. & Holborow, E.J. (1976) Contractile proteins in human cancer cells. American Journal of Pathology, 83, 457–466. Gasic, G.J., Boettiger, D., Catalfamo, J.L., Gasic, T.B. & Stewart, G.J. (1978) Aggregation of platelets and cell membrane vesiculation by rat cells transformed ‘in vitro’ by Rous sarcoma virus. Cancer Research, 38, 2950–2955. Gasic, G.J., Catalfamo, J.L., Gasic, T.B. & Avdalovic, N. (1979) In vitro mechanisms of platelet aggregation (PA) by purified plasma membrane vesicles (PMV) shed by mouse 15091A tumor cells. Thrombosis and Haemostasis, 42, 351. Gasic, G.J., Gasic, T.B., Galanti, N., Johnson, T. & Murphy, S. (1973) Platelet-tumor-cell interactions in mice. The role of platelets in the spread of malignant disease. International Journal of Cancer, 11, 704–718. Gasic, G.J., Gasic, T.B. & Stewart, C.C. (1968) Antimetastatic effects associated with platelet reduction. Proceedings of the National Academy of Sciences of the United States of America, 61, 46–52. Goldstein, S. & Niewiarowski, S. (1976) Increased procoagulant activity in cultured fibroblasts from progeria and Werner's syndromes of premature ageing. Nature, 260, 711–713. Gordon, S.G., Franks, J.J. & Lewis, B. (1975) Cancer procoagulant A: a factor X activating procoagulant from malignant tissue. Thrombosis Research, 6, 127–137. Gordon, S.G. & Lewis, B.J. (1978) Comparison of procoagulant activity in tissue culture medium from normal and transformed fibroblasts. Cancer Research, 38, 2467–2472. Gralnick, H.R., Bagley, J. & Abrell, E. (1972) Heparin treatment for the hemorrhagic diathesis of acute promyelocytic leukemia. American Journal of Medicine, 52, 167–174. Gralnick, H.R. & Tan, H.K. (1974) Acute promyelocytic leukemia. A model for understanding the role of the malignant cell in hemostasis. Human Pathology, 5, 661–673. Hamilton, J., Vassalli, J.D. & Reich, E. (1976) Macrophage plasminogen activator: Induction by asbestos is blocked by anti-inflammatory steroids. Journal of Experimental Medicine, 144, 1689–1694. Hilgard, P. (1977) Experimental vitamin K deficiency and spontaneous metastases. British Journal of Cancer, 35, 891–892. Hilgard, P. (1978) Blood platelets and experimental metastases. Platelets: A Multidisciplinary Approach (ed. by G. Gaetano and S. Garattini), pp. 457–466. Raven Press, New York . Hilgard, P. & Hiemeyer, V. (1970) Fibrinolysis, thromboplastin activity and localization of radioiodinated fibrinogen in experimental tumors. European Journal of Cancer, 6, 157–158. Hilgard, P., Schulte, H., Wetzig, G., Schmitt, G. & Schmidt, C.G. (1977) Oral anticoagulation in the treatment of a spontaneous metastasising murine tumour (3LL). British Journal of Cancer, 35, 78–85. Hilgard, P. & Thornes, R.D. (1976) Anticoagulants in the treatment of cancer. European Journal of Cancer, 12, 755–762. Hoover, H.C., Jr, Jones, D. & Ketcham, A.S. (1976) The optimal level of anticoagulation for decreasing experimental metastases. Surgery, 79, 625–630. Hoover, H.C., Jr, Ketcham, A.S., Millar, R.C. & Gralnick, H.R. (1978) Osteosarcoma. Improved survival with anticoagulation and amputation. Cancer, 41, 2475–2480. Kepner, N., Creasy, G. & Lipton, A. (1978) Platelets as a source of cell-proliferating activity. Platelets: A Multidisciplinary Approach (ed. by G. Gaetano and S. Garattini), pp. 205–212. Raven Press, New York . Kirsch, W.M., Schulz, D., Van Buskirk, J.J. & Young, H.E. (1974) Effects of sodium warfarin and other carcinostatic agents on malignant cells: a study of drug synergy. Journal of Medicine, 5, 69–82. Loskutoff, D.J. & Edgington, T.S. (1977) Synthesis of a fibrinolytic activator and inhibitor by endothelial cells. Proceedings of the National Academy of Sciences of the United States of America, 74, 3903–3907. Lynch, N.R., Castes, M., Astoin, M. & Salomon, J.C. (1978) Mechanism of inhibition of tumour growth by aspirin and indomethacin. British Journal of Cancer, 38, 503–512. Marrack, D., Kubala, M., Corry, P., Leavens, M., Howze, J., Dewey, W., Bale, W.F. & Spar, I.L. (1967) Localization of intracranial tumors. Comparative study with 131-I-labeled antibody to human fibrinogen and neohydrin-203 Hg. Cancer, 20, 751–755. Miskin, R., Easton, T.G. & Reich, E. (1978) Plasminogen activator in chick embryo muscle cells: Induction of enzyme by RSV, PMA and retinoic acid. Cell, 15, 1301–1312. Moncada, S. & Vane, J.R. (1978) Prostacyclin, platelet aggregation and thrombosis. Platelets: A Multidisciplinary Approach (ed. by G. Gaetano and S. Garattini), pp. 239–259. Raven Press, New York . Mott, D.M., Fabisch, P.H., Sani, B.P. & Sorof, S. (1974) Lack of correlation between fibrinolysis and the transformed state of cultured mammalian cells. Biochemical and Biophysical Research Communications, 61, 621–627. Mussoni, L., Bertoni, M.P., Curatolo, L., Poggi, A. & Donati, M.B. (1977a) ‘In vitro’ interactions of L5222 and BNML leukemia cells with fibrin. A preliminary report. Leukemia Research, 1, 181–183. Mussoni, L., Poggi, A., De Gaetano, G. & Donati, M.B. (1978) Effect of ditazole, an inhibitor of platelet aggregation, on a metastatizing tumour in mice. British Journal of Cancer, 37, 126–129. Mussoni, L., Poggi, A., Donati, M.B. & De Gaetano, G. (1977b) Ditazole and platelets. III. Effect of ditazole on tumor-cell induced thrombocytopenia and on bleeding time in mice. Haemostasis, 6, 260–265. Muszbek, L. & Laki, K. (1974) Cleavage of actin by thrombin. Proceedings of the National Academy of Sciences of the United States of America, 71, 2208–2211. Nachman, R.L. (1978) The platelet as an inflammatory cell. Platelets: A Multidisciplinary Approach (ed. by G. Gaetano and S. Garattini), pp. 199–203. Raven Press, New York . Nagy, B., Ban, J. & Brdar, B. (1977) Fibrinolysis associated with human neoplasia: Production of plasminogen activator by human tumours. International Journal of Cancer, 19, 614–620. Nicolson, G.L. (1977) Cell surfaces and blood-borne tumor metastasis. Progress in Cancer Research and Therapy, 5, 163–174. Nicolson, G.L., Winkelhake, J.L. & Nussey, A.C. (1976) An approach to studying the cellular properties associated with metastasis: some in vitro properties of tumor variants selected in vivo for enhanced metastasis. Fundamental Aspects of Metastasis (ed. by L. Weiss), pp. 291–303. North-Holland, Amsterdam . Niewiarowski, S. & Goldstein, S. (1973) Interaction of cultured human fibroblasts with fibrin: modification by drugs and aging in vitro. Journal of Laboratory and Clinical Medicine, 82, 605–610. Niewiarowski, S., Regoeczi, E. & Mustard, J.F. (1972) Adhesion of fibroblasts to polymerizing fibrin and retraction of fibrin induced by fibroblasts. Proceedings of the Society for Experimental Biology and Medicine, 140, 199–204. O'Meara, R.A.Q. (1958) Coagulative properties of cancers. Irish Journal of Medical Sciences, No. 394, 474–479. Pearlstein, E., Cooper, L.B. & Karpatkin, S. (1979) Extraction and characterization of a platelet aggregating material (PAM) from SV40-transformed mouse 3T3 fibroblasts. Journal of Laboratory and Clinical Medicine, 93, 332–334. Pearlstein, E., Hynes, R.O., Franks, L.M. & Hemmings, V.J. (1976) Surface proteins and fibrinolytic activity of cultured mammalian cells. Cancer-Research, 36, 1475–1480. Plow, E.F. & Edgington, T.S. (1975) An alternative pathway for fibrinolysis. I. The cleavage of fibrinogen by leukocyte proteases at physiologic pH. Journal of Clinical Investigation, 56, 30–38. Poggi, A., Dall'Olio, A., Balconi, G., Delaini, F., De Gaetano, G. & Donati, M.B. (1979) Generation of prostacyclin (PGI2) activity by Lewis lung carcinoma (3LL) cells. Thrombosis and Haemostasis, 42, 339. Poggi, A., Donati, M.B., Polentarutti, N., De Gaetano, G. & Garattini, S. (1976) On the thrombocytopenia developing in mice bearing a spontaneously metastasizing tumor. Zeitschrift für Krebsforschung, 86, 303–306. Poggi, A., Mussoni, L., Kornblihtt, L., Ballabio, E., De Gaetano, G. & Donati, M.B. (1978) Warfarin enantiomers, anticoagulation and experimental tumour metastasis. Lancet, i, 163–164. Poggi, A., Polentarutti, N., Donati, M.B., De Gaetano, G. & Garattini, S. (1977) Blood coagulation changes in mice bearing Lewis lung carcinoma, a metastasizing tumor. Cancer Research, 37, 272–277. Pohjanpelto, P. (1979) Synergistic effect of thrombin and platelet extract on growth of human fibroblasts. Thrombosis Research, 14, 353–362. Pollack, R. & Rifkin, D. (1975) Actin-containing cables within anchorage-dependent rat embryo cells are dissociated by plasmin and trypsin. Cell, 6, 495–506. Quintana, A., Raczka, E. & Donati, M.B. (1979) Different responses to noradrenaline (NA) of vascular tissues from two metastasizing tumours in mice. Thrombosis and Haemostasis, 42, 140. Raczka, E., Quintana, A., Poggi, A. & Donati, M.B. (1979) Cardiac output distribution in mice bearing Lewis lung carcinoma (3LL) or JW sarcoma (JWS), two spontaneously metastasizing tumours. Thrombosis and Haemostasis, 42, 142. Ratnoff, O.D. (1974) Some recent advances in the study of haemostasis. Circulation Research, 35, 1–14. Rifkin, D.B., Beal, L.P. & Reich, E. (1975) Macromolecular determinants of plasminogen activator synthesis. Proteases and Biological Control (ed. by D. B. Rifkin, E. Reich and E. Shaw), pp. 841–847. Cold Spring Harbor Labs., New York . Rohwedder, J.J. & Sagastume, E. (1977) Heparin and polychemotherapy for treatment of lung cancer. Cancer Treatment Report, 61, 1399–1401. Ross, R. & Vogel, A. (1978) The platelet-derived growth factor: a review. Cell, 14, 203–210. Sakuragawa, N., Takahashi, K., Hoshiyama, M., Jimbo, C., Ashizawa, K., Matsuoka, M. & Ohnishi, Y. (1977) The extract from the tissue of gastric cancer as procoagulant in disseminated intravascular coagulation syndrome. Thrombosis Research, 10, 457–463. Santoro, M.G., Philpott, G.W. & Jaffe, B.M. (1976) Inhibition of tumour growth in vitro and in vitro by prostaglandin E. Nature, 263, 777–779. Semeraro, N. & Vermylen, J. (1977) Evidence that washed human platelets possess factor X activator activity. British Journal of Haematology, 36, 107–115. Spreafico, F. & Garattini, S. (1974) Selective antimetastatic treatment-current status and future prospects. Cancer Treatment Reviews, 1, 239–250. Strickland, S., Reich, E. & Sherman, M.I. (1976) Plasminogen activator in early embryogenesis: enzyme production by trophoblast and parietal endoderm. Cell, 9, 231–240. Svanberg, L. (1975) Thromboplastic activity of human ovarian tumours. Thrombosis Research, 6, 307–313. Takaki, A., Yamaguchi, T. & Ohsato, K. (1974) Kinin-like activities of the synthetic low molecular weight fragments of fibrinogen degradation products. Thrombosis et Diathesis Haemorrhagica, 32, 350–355. Thornes, R.D. (1974) Oral anticoagulant therapy of human cancer. Journal of Medicine, 5, 83–91. Thornes, R.D. (1975) Adjuvant therapy of cancer via the cellular immune mechanism or fibrin by induced fibrinolysis and oral anticoagulants. Cancer, 35, 91–97. Thornes, R.D., Deasy, P.F., Carroll, R., Reen, D.J. & MacDonell, J.D. (1972) The use of the proteolytic enzyme kinase to produce autocytotoxicity in patients with acute leukemia and its possible role in immunotherapy. Cancer Research, 32, 280–284. Unkeless, J.C., Gordon, S. & Reich, E. (1974) Secretion of plasminogen activator by stimulated macrophages. Journal of Experimental Medicine, 139, 834–850. Unkeless, J.C., Tobia, A., Ossowki, L., Quigley, J.P., Rifkin, D.B. & Reich, E. (1973) An enzymatic function associated with transformation of fibroblasts by oncogenic viruses. I. Chick embryo fibroblast cultures transformed by avian RNA-tumor viruses. Journal of Experimental Medicine, 137, 85–111. A. Vaheri, E. Ruoslahti & D.F. Mosher, (eds.) (1978) Fibroblast Surface Protein, Annals of the New Academy of Sciences, Vol. 312. Warren, B.A. (1973) Environment of the bloodborne tumor embolus adherent to vessel wall. Journal of Medicine, 4, 150–177. Warren, B.A. (1978) Platelet-tumor cell interactions: morphological studies. Platelets: A Multidisciplinary Approach (ed. by G. Gaetano and S. Garattini), pp. 427–446. Raven Press, New York . Zacharski, L.R. & Rosenstein, R. (1979) Reduction of salivary tissue factor (thromboplastin) activity by warfarin therapy. Blood, 53, 366–374. Citing Literature Volume44, Issue2February 1980Pages 173-182 ReferencesRelatedInformation